Soluble interleukin-2 receptors: levels in leprosy, and during and after type 1 (lepra) and type 2 (ENL) reactions.
Twenty-five patients with Type 1 (lepra) and Type 2 (ENL) reactions, were assayed for SIL-2R in serum--before and after treatment for their acute condition--and the results were compared with 10 normal healthy adults and 20 patients of leprosy per se. Classification of each subject into different leprosy groups, and into various types and subtypes of reactions, was done according to standard criteria, prior to inclusion into the study. Detailed statistical evaluation of the data revealed significantly higher levels of SIL-2R in all leprosy patients, as compared to normal controls, with higher levels in the multibacillary groups as compared to the paucibacillary group. SIL-2Rs appeared higher in Type 1 upgrading reaction than in other forms of reaction, though this was not statistically significant. There was no significant change in levels following treatment and clinical remission.
Sehgal
V N
VN
Department of Dermatology, Maulana Azad Medical College, New Delhi, India.
Bhattacharya
S N
SN
Shah
Y
Y
Sharma
V K
VK
Gupta
C K
CK
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D012995:Solubility
D015375:Receptors, Interleukin-2